Migraine is a common neurological syndrome that affects approximately 10–20% of the population. The pathophysiology of migraine is unclear. 5-hydroxytriptamine is a key mediator in the ...
Madigan Army Medical Center, Department of Pediatrics, University of Washington Medical School, Seattle WA, USA. Tel.: + 253 307 7544, Fax.: +253 968 0384, neil ...
How much vitamin D is enough? Over the past decade, rickets has re-emerged as a noticeable public health issue in some areas (Lanham-New et al, 2010) and many physicians have been ordering lab ...
Breast imaging has made huge advances in the last decade, and along with newer techniques to diagnose primary breast cancer, many novel methods are being used and look promising in detecting ...
Two reviewers (IPK and KGM) independently searched the aforementioned databases to identify potentially eligible trials. To be included in our analysis, a trial had to be an RCT, and to focus on ...
Objective: To compare pain control, patient preference and tolerability for two extended-release formulations of morphine sulfate, Kadian ® capsules (administered once daily) and MS Contin ...
Although often viewed as benign injuries, clavicular fractures can lead to complications, particularly nonunions. The nonunion rate has been reported to be between 0.1% and 15%. Contributing ...
Background: The aim of this study was to develop and psychometrically test a short, patient-reported questionnaire to be used in clinical practice for patients with Irritable Bowel Syndrome (IBS).
Polymyalgia rheumatica (PMR) is a common inflammatory condition affecting elderly people and involving the girdles. [1] The mainstay of treatment is oral glucocorticoids (GC), with the recent BSR ...
Globally, it is possible that less than half of all patients are treated in compliance with guidelines and more than half of all patients fail to take their medicines as prescribed or dispensed.
Robert F. Kennedy, Jr, will lead the nation’s largest health and human services agency after today’s US Senate vote. Many ...
The US Food and Drug Administration has approved vimseltinib (Romvimza, Deciphera Pharmaceuticals, LLC) to treat adult ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results